ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 216 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $812,000 | -95.9% | 8,732 | -96.9% | 0.00% | -96.2% |
Q1 2021 | $19,784,000 | -44.7% | 285,115 | -38.8% | 0.03% | -49.0% |
Q4 2020 | $35,765,000 | +1901.4% | 465,510 | +1847.7% | 0.05% | +1600.0% |
Q3 2020 | $1,787,000 | -74.7% | 23,900 | -84.6% | 0.00% | -81.2% |
Q4 2019 | $7,069,000 | +49.1% | 155,628 | +92.4% | 0.02% | +45.5% |
Q2 2019 | $4,741,000 | +984.9% | 80,871 | +631.4% | 0.01% | +1000.0% |
Q1 2018 | $437,000 | – | 11,057 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |